Overview
Join McDermott Will & Schulte and EY for a timely discussion on the forces shaping today’s global life sciences market. Building on insights from our annual McDermott Forum at JPM, this webinar will take a deeper look at the trends actually moving the needle across biopharma, MedTech, and diagnostics now that we are halfway through 2026.
With the industry heading into a critical stretch leading up to major convenings – including McDermott’s Life Sciences Investment Forum and the AdvaMed Conference – we’ll cut through the noise and focus on what matters most for investors, operators, and innovators right now, including the growing impact of cross-border dynamics and China’s evolving role in the global life sciences ecosystem.
Discussion topics include:
- The current state of life sciences deal activity – and where momentum is (and isn’t) building
- Capital formation trends across biotech, MedTech, and emerging platforms
- Strategic shifts in partnerships, licensing, and M&A
- Regulatory, reimbursement, and policy dynamics impacting growth and exits
- What to watch heading into the second half of the year